Telephone
N/A
Address
2nd Floor 13-15 Bouverie Street Harmsworth House London, Greater London EC4Y 8DP
Description
Doctor Care Anywhere Group PLC is a telehealth company, which engages in delivering care to its patients, whilst reducing the overall cost of providing clinical services. It operates through the following segments: Primary Care, Secondary Care, and Remote Care. The Primary Care segment includes general practice, pharmacy, dental, and optician services. The Secondary Care segment covers medical specialties and levels of clinical acuity, meaning the severity of a patient's illness or condition which determines the level of attention or service they will need from professional staff. The Remote Care segment involves the use of remote medical devices that track patients’ health data and report results automatically. The company was founded by Bayju Thakar and David Jeremy Ravech on February 27, 2014 and is headquartered in London, the United Kingdom.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.04 - 0.09
Trade Value (12mth)
US$3,666.00
1 week
-4.08%
1 month
-14.55%
YTD
-4.08%
1 year
-21.67%
All time high
1.52
EPS 3 yr Growth
12366.500%
EBITDA Margin
-69.20%
Operating Cashflow
-£15m
Free Cash Flow Return
-67.90%
ROIC
-98.30%
Interest Coverage
-267.80
Quick Ratio
1.20
Shares on Issue (Fully Dilluted)
367m
HALO Sector
Healthcare
Next Company Report Date
21-Feb-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
GBP
Short Sell (% of issue)
0.02
Date | Announcements |
---|---|
31 October 22 |
Quarterly Activity Report & Appendix 4C for 3Q 2022
×
Quarterly Activity Report & Appendix 4C for 3Q 2022 |
31 March 22 |
2021 Annual Report and Corporate Governance Statement
×
2021 Annual Report and Corporate Governance Statement |
31 March 22 |
Appendix 4G
×
Appendix 4G |
31 March 21 |
2020 Annual Report and Corporate Governance Statement
×
2020 Annual Report and Corporate Governance Statement |
31 January 23 |
Chairman Appointment/Resignation
×
Chairman Appointment/Resignation |
31 August 23 |
Half Yearly Report and Accounts
×
Half Yearly Report and Accounts |
31 August 23 |
Interim Financial Report & Appendix 4D Results Announcement
×
Interim Financial Report & Appendix 4D Results Announcement |
29 March 23 |
AGM Chair and CEO Addresses
×
AGM Chair and CEO Addresses |
29 March 23 |
AGM Results
×
AGM Results |
29 July 22 |
Quarterly Activity Report & Appendix 4C for 2Q 2022
×
Quarterly Activity Report & Appendix 4C for 2Q 2022 |
29 August 22 |
Interim Financial Report & Appendix 4D
×
Interim Financial Report & Appendix 4D |
28 March 22 |
Application for quotation of securities - DOC
×
Application for quotation of securities - DOC |
28 July 21 |
Investor Presentation 2Q 2021 Trading Update
×
Investor Presentation 2Q 2021 Trading Update |
28 January 22 |
Quarterly Activity Report/ Appendix 4C - 4Q 2021
×
Quarterly Activity Report/ Appendix 4C - 4Q 2021 |
28 January 22 |
Investor Presentation - 4Q 2021
×
Investor Presentation - 4Q 2021 |
28 January 21 |
4Q 2020 Investor Presentation - Amendment
×
4Q 2020 Investor Presentation - Amendment |
28 February 23 |
Appendix 4E FY22 Preliminary Final Report
×
Appendix 4E FY22 Preliminary Final Report |
28 February 23 |
Investor Presentation FY22 Results
×
Investor Presentation FY22 Results |
28 February 22 |
DOC Closes A$11.2m Placement and Launches A$1m SPP
×
DOC Closes A$11.2m Placement and Launches A$1m SPP |
28 February 22 |
Preliminary FY 2021 Results Announcement & Appendix 4E
×
Preliminary FY 2021 Results Announcement & Appendix 4E |
28 February 22 |
Investor Presentation FY21 Prelim Results & Capital Raising
×
Investor Presentation FY21 Prelim Results & Capital Raising |
28 February 22 |
Proposed issue of securities - DOC
×
Proposed issue of securities - DOC |
27 November 23 |
Announcement of Auditor Appointment and Resignation
×
Announcement of Auditor Appointment and Resignation |
27 January 23 |
Clarification on Cash Outflows in Appendix 4c
×
Clarification on Cash Outflows in Appendix 4c |
27 January 22 |
Doctor Care Anywhere finalises contract with Nuffield Health
×
Doctor Care Anywhere finalises contract with Nuffield Health |
27 January 21 |
4Q 2020 Investor Presentation
×
4Q 2020 Investor Presentation |
27 April 23 |
Quarterly Activity Report & Appendix 4C for 1Q 2023
×
Quarterly Activity Report & Appendix 4C for 1Q 2023 |
27 April 22 |
Appendix 3Z - Jonathan Baines
×
Appendix 3Z - Jonathan Baines |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.